Final Results of the Phase II SAPHIRE Trial of Resminostat (4SC-201) in Patients with Relapsed/Refractory Hodgkin Lymphoma
Autor: | Walewski, Jan, Paszkiewicz-Kozik, Ewa *, Warszewska, Agnieszka *, Borsaru, Gabriela *, Moicean, Andreea *, Hellmann, Andrzej *, Mayer, Jiri, Hauns, Bernhard *, Mais, Anna *, Henning, Stefan W. *, Hentsch, Bernd * |
---|---|
Zdroj: | In Blood 18 November 2011 118(21):2675-2675 |
Databáze: | ScienceDirect |
Externí odkaz: |